Pfizer is one of the largest pharmaceutical companies in the world by market capitalization and has gained a lot of steam over the past few quarters given its success on the Covid-19 vaccine front. While its revenue growth from the past few years was relatively slow on account of the sale of its consumer healthcare business as well as its generic drugs business, there is a robust upside expected from the success of many of its key drugs such as Ibrance, Vyndaqel, Eliquis, Xeljanz, and Vyndaqel. ....
17 Jun 2021
Pfizer Inc. - Financial & Price Forecasts, DCF Valuation
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Pfizer Inc. - Financial & Price Forecasts, DCF Valuation
Pfizer Inc. (PFE:NYS), 0 | Pfizer Inc. (0Q1N:LON), 2,780
- Published:
17 Jun 2021 -
Author:
Ishan Majumdar -
Pages:
14
Pfizer is one of the largest pharmaceutical companies in the world by market capitalization and has gained a lot of steam over the past few quarters given its success on the Covid-19 vaccine front. While its revenue growth from the past few years was relatively slow on account of the sale of its consumer healthcare business as well as its generic drugs business, there is a robust upside expected from the success of many of its key drugs such as Ibrance, Vyndaqel, Eliquis, Xeljanz, and Vyndaqel. ....